Definition
Conantokin G (Con G) toxin found in the venom of cone snails is a 17-amino-acid competitive antagonist of N-methyl-D-aspartate (NMDA) receptors containing NR2B subunits1.
Discovery
Conantokins were first discovered and isolated from the venom of cone snail, Conus geographus as it induced a sleep-like state in mice2.
Classification
Conantokins belong to a unique family of ?-carboxyglutamic acid-containing Conus peptides. There are three members of conantokins that have been identified so far- Conantokins G, T and R3.
Structural Characteristics
Con G has the sequence- H - Gly - Glu - Gla - Gla - Leu - Gln - Gla - Asn - Gln - Gla - Leu - Ile - Arg - Gla - Lys - Ser - Asn - NH21. It is a linear peptide that possesses a high degree of alpha-helicity in the presence of divalent cations, and contains gamma-carboxyglutamic acid residues1.
Mode of action
Con G undergoes several post translational processing one of which is the vitamin K-dependent gamma-carboxylation of glutamate that results in placement of gamma-carboxyglutamic acid residues in these peptides4. As a result, these peptides then possess the ability to interact with divalent metal ions and concomitantly undergo a conformational alteration4. They then interact with the glutamate binding pocket of NMDA receptors and inhibit them5.
Functions
The pharmacological selectivity of the Con G, coupled with its efficacy in preclinical models of disease indicate that it can be used as a probe for NMDA receptor function as well as for continued investigation as human therapeutics1.
References
1.Layer RT, Wagstaff JD, White HS (2004). Conantokins: peptide antagonists of NMDA receptors. Curr Med Chem, 1(23):3073-84.
2.McIntosh JM, Olivera BM, Cruz LJ, Gray WR (1984). Gamma-carboxyglutamate in a neuroactive toxin. J Biol Chem, 10; 259(23):14343-6.
3.Prorok M, Castellino FJ (2001). Structure-function relationships of the NMDA receptor antagonist conantokin peptides. Curr Drug Targets, 2(3):313-22.
4.Castellino FJ, Prorok M (2000). Conantokins: inhibitors of ion flow through the N-methyl-D-aspartate receptor channels. Curr Drug Targets, 1(3):219-35.
5.Wittekindt B, Malany S, Schemm R, Otvos L, Maccecchini ML, Laube B and Betz H (2006). Point mutations identify the glutamate binding pocket of the N-methyl- -aspartate receptor as major site of Conantokin-G inhibition. Neuropharmacology
41 (6), 753-761.
Tuesday, August 18, 2009
Conopressin Peptide and Analogs
Definition
Conopressin is a nonapeptide that is expressed in the central nervous system and it acts like a neurotransmitter in mollusks1.
Discovery
Conopressin activity was first extracted from mollusk ganglia in 19752.
Classification
Conopressin belongs to vasopressin-like peptide family3.
Structural Characteristics
Conopressin consists of a carboxy terminal amidation signal, an endoproteoltytic processing site and a neurophysin domain4. Several structural analogs of conopressin- G,T and S have been identified4.
Mode of action
It is known that conopressins exert their functions via binding to G-protein coupled receptors4.
Functions
Conopressin affects excitability, firing, and action potential shape through stimulation of transient and persistent inward currents in mulluscan neurons1. It also modulates gill behavior1.
References
1.van Soest PF, Kits KS (1998). Conopressin affects excitability, firing, and action potential shape through stimulation of transient and persistent inward currents in molluscan neurons. J Neurophysiol, 79(4):1619-32.
2.Ifshin, M. S., Gainer, H and Barker, J. L (1975). Peptide factor extracted from molluscan ganglia that modulates bursting pacemaker activity. Nature, 254: 72–74.
3.Dutertre S, Croker D, Daly NL, Andersson A, Muttenthaler M, Lumsden NG, Craik DJ, Alewood PF, Guillon G, Lewis RJ (2008). Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides. J Biol Chem, 283(11):7100-8.
4.Book: Structure and function of primary messengers in invertebrates. Klaus W. Beyenbach, 12-13.
Conopressin is a nonapeptide that is expressed in the central nervous system and it acts like a neurotransmitter in mollusks1.
Discovery
Conopressin activity was first extracted from mollusk ganglia in 19752.
Classification
Conopressin belongs to vasopressin-like peptide family3.
Structural Characteristics
Conopressin consists of a carboxy terminal amidation signal, an endoproteoltytic processing site and a neurophysin domain4. Several structural analogs of conopressin- G,T and S have been identified4.
Mode of action
It is known that conopressins exert their functions via binding to G-protein coupled receptors4.
Functions
Conopressin affects excitability, firing, and action potential shape through stimulation of transient and persistent inward currents in mulluscan neurons1. It also modulates gill behavior1.
References
1.van Soest PF, Kits KS (1998). Conopressin affects excitability, firing, and action potential shape through stimulation of transient and persistent inward currents in molluscan neurons. J Neurophysiol, 79(4):1619-32.
2.Ifshin, M. S., Gainer, H and Barker, J. L (1975). Peptide factor extracted from molluscan ganglia that modulates bursting pacemaker activity. Nature, 254: 72–74.
3.Dutertre S, Croker D, Daly NL, Andersson A, Muttenthaler M, Lumsden NG, Craik DJ, Alewood PF, Guillon G, Lewis RJ (2008). Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides. J Biol Chem, 283(11):7100-8.
4.Book: Structure and function of primary messengers in invertebrates. Klaus W. Beyenbach, 12-13.
CSK-17 and Fragments
Definition
C-terminal Src kinase (CSK) is an endogenous inhibitor of Src family of protoongogenic protein kinases. It phosphorylates these kinases at a specific Tyr-504 residue1.
Discovery
CSK activity was first described in 19912.
Classification
CSK belongs to the tyrosine kinase family of proteins1.
Structural Characteristics
CSK is a 50 Kda protein. Its structure consists of a small, N-terminal lobe made up of a beta-sheet, and a larger C-terminal lobe made up mostly of alpha-helices3. The structure reveals atomic details of interactions with staurosporine, which binds in a deep cleft between the lobes. Interactions between the N and C-terminal lobe are mediated by the bound staurosporine molecule and by hydrogen bonds3. In addition, there are several water molecules forming lobe-bridging hydrogen bonds, which may be important for maintaining catalytic integrity of the kinase. CSK all in all has three major domains, SH2, SH3 and kinase domains3.
Mode of action
CSK first binds to transmambrane proteins through its SH2, SH3 and kinase domains which facilitates its translocation to the plasma membrane4. It then binds to Src kinase and phosphorylates it at the Tyr-504 residue4. This phosphorylation results in conformational changes in Src kinase which lead to its inactivation4.
Functions
Csk catalyzes a tail phosphorylation reaction on Src and thereby restrains Src's activity and oncogenic potential5.
References
1.Book: Drug discovery handbook. By Shayne C. Gad, 1198-1199.
2.Okada M and Nakagawa H (1989). A protein-tyrosine kinase involved in regulation of pp60c-src function. J. Biol. Chem., 264, 20886–20893.
3.Lamers MBAC, Antson A, Scott RG, Hubbard RE and Williams DH (1999). Structure of the Protein Tyrosine Kinase Domain of C-terminal Src Kinase (CSK) in Complex with Staurosporine. J. Mol. Biol., 285 (2), 712-725.
4.Chong YP, Mulhern TD, Cheng HC (2005). C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases. Growth Factors, 23(3), 233-44.
5.Cole PA, Shen K, Qiao Y, Wang D (2003). Protein tyrosine kinases Src and Csk: a tail's tale. Curr Opin Chem Biol., 7(5):580-5.
C-terminal Src kinase (CSK) is an endogenous inhibitor of Src family of protoongogenic protein kinases. It phosphorylates these kinases at a specific Tyr-504 residue1.
Discovery
CSK activity was first described in 19912.
Classification
CSK belongs to the tyrosine kinase family of proteins1.
Structural Characteristics
CSK is a 50 Kda protein. Its structure consists of a small, N-terminal lobe made up of a beta-sheet, and a larger C-terminal lobe made up mostly of alpha-helices3. The structure reveals atomic details of interactions with staurosporine, which binds in a deep cleft between the lobes. Interactions between the N and C-terminal lobe are mediated by the bound staurosporine molecule and by hydrogen bonds3. In addition, there are several water molecules forming lobe-bridging hydrogen bonds, which may be important for maintaining catalytic integrity of the kinase. CSK all in all has three major domains, SH2, SH3 and kinase domains3.
Mode of action
CSK first binds to transmambrane proteins through its SH2, SH3 and kinase domains which facilitates its translocation to the plasma membrane4. It then binds to Src kinase and phosphorylates it at the Tyr-504 residue4. This phosphorylation results in conformational changes in Src kinase which lead to its inactivation4.
Functions
Csk catalyzes a tail phosphorylation reaction on Src and thereby restrains Src's activity and oncogenic potential5.
References
1.Book: Drug discovery handbook. By Shayne C. Gad, 1198-1199.
2.Okada M and Nakagawa H (1989). A protein-tyrosine kinase involved in regulation of pp60c-src function. J. Biol. Chem., 264, 20886–20893.
3.Lamers MBAC, Antson A, Scott RG, Hubbard RE and Williams DH (1999). Structure of the Protein Tyrosine Kinase Domain of C-terminal Src Kinase (CSK) in Complex with Staurosporine. J. Mol. Biol., 285 (2), 712-725.
4.Chong YP, Mulhern TD, Cheng HC (2005). C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases. Growth Factors, 23(3), 233-44.
5.Cole PA, Shen K, Qiao Y, Wang D (2003). Protein tyrosine kinases Src and Csk: a tail's tale. Curr Opin Chem Biol., 7(5):580-5.
CK II (Casein Kinase II)
Definition
Casein Kinases II is a Ser/Thr protein kinase that has been implicated in cell cycle control, circadian rhythm, DNA repair and other cellular processes1.
Discovery
Casein Kinase II was first purified from rabbit erythrocytes in 19752.
Classification
Casein Kinase II belongs to the Ser/Thr protein kinase family which includes Casein Kinase I as well. The catalytic subunit of casein kinase II has three isoforms, CKII-alpha, alpha’ and alpha” while the regulatory subunit CK II-beta is common to all three catalytic subunits3.
Structural Characteristics
Casein Kinase II is a tetramer with two alpha subunits and two beta subunits. The alpha subunit has an ATP binding pocket3.
Mode of action
Casein Kinase II prefers acidic substrates and phosphorylates proteins with a minimum consensus sequence of Ser-X-X-Acidic, where the acidic residue may be Glu, Asp, pSer or pTyr3.
Functions
Casein Kinase II is widely distributed in various regions of cell and body that reflects its diverse functions. Several 100 substrates of casein kinase II have been identified so far. High levels of Casein Kinase II have been found in several cancers including breast, prostate, lung, head and kidney3. It is required for G1/S and G2/M transitions during cell cycle4. It also phosphorylates proteins involved in DNA repair5. Casein Kinase II promotes cell survival and protects cells from drug induced apoptosis3. Casein kinase 2 activity has been reported to be activated following Wnt signaling pathway activation6.
References
1.Toselli XXP, Russell L and Seldin D (1999). "Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit". Nature Genetics, 23, 118-121.
2.Kumar R, Tao M (1975). Multiple forms of casein kinase from rabbit erythrocytes. Biochim Biophys Acta, 410(1), 87-98.
3.Litchfield DW (2003). Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J, 369 (1), 1-15.
4.Litchfield DW, Lüscher B, Lozeman FJ, Eisenman RN, Krebs EG (1992). Phosphorylation of casein kinase II by p34cdc2 in vitro and at mitosis. J Biol Chem, 267(20), 13943-51.
5.Loizou JI, El-Khamisy SF, Zlatanou A, Moore DJ, Chan DW, Qin J, Sarno S, Meggio F, Pinna LA, Caldecott KW (2004). The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks. Cell, 117(1), 17-28.
6.Gao Y, Wang HY (2006). Casein kinase 2 is activated and essential for Wnt/beta-catenin signaling. J Biol Chem, 281(27), 18394-400.
Casein Kinases II is a Ser/Thr protein kinase that has been implicated in cell cycle control, circadian rhythm, DNA repair and other cellular processes1.
Discovery
Casein Kinase II was first purified from rabbit erythrocytes in 19752.
Classification
Casein Kinase II belongs to the Ser/Thr protein kinase family which includes Casein Kinase I as well. The catalytic subunit of casein kinase II has three isoforms, CKII-alpha, alpha’ and alpha” while the regulatory subunit CK II-beta is common to all three catalytic subunits3.
Structural Characteristics
Casein Kinase II is a tetramer with two alpha subunits and two beta subunits. The alpha subunit has an ATP binding pocket3.
Mode of action
Casein Kinase II prefers acidic substrates and phosphorylates proteins with a minimum consensus sequence of Ser-X-X-Acidic, where the acidic residue may be Glu, Asp, pSer or pTyr3.
Functions
Casein Kinase II is widely distributed in various regions of cell and body that reflects its diverse functions. Several 100 substrates of casein kinase II have been identified so far. High levels of Casein Kinase II have been found in several cancers including breast, prostate, lung, head and kidney3. It is required for G1/S and G2/M transitions during cell cycle4. It also phosphorylates proteins involved in DNA repair5. Casein Kinase II promotes cell survival and protects cells from drug induced apoptosis3. Casein kinase 2 activity has been reported to be activated following Wnt signaling pathway activation6.
References
1.Toselli XXP, Russell L and Seldin D (1999). "Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit". Nature Genetics, 23, 118-121.
2.Kumar R, Tao M (1975). Multiple forms of casein kinase from rabbit erythrocytes. Biochim Biophys Acta, 410(1), 87-98.
3.Litchfield DW (2003). Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J, 369 (1), 1-15.
4.Litchfield DW, Lüscher B, Lozeman FJ, Eisenman RN, Krebs EG (1992). Phosphorylation of casein kinase II by p34cdc2 in vitro and at mitosis. J Biol Chem, 267(20), 13943-51.
5.Loizou JI, El-Khamisy SF, Zlatanou A, Moore DJ, Chan DW, Qin J, Sarno S, Meggio F, Pinna LA, Caldecott KW (2004). The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks. Cell, 117(1), 17-28.
6.Gao Y, Wang HY (2006). Casein kinase 2 is activated and essential for Wnt/beta-catenin signaling. J Biol Chem, 281(27), 18394-400.
Cocaine- and Amphetamine-Regulated Transcript (CART) Fragments
Definition
Cocaine and amphetamine regulated transcript (CART) is a neuropeptide which in humans is encoded by the CARTPT gene and has roles in reward, feeding, and stress, and it has the functional properties of an endogenous psychostimulant1.
Discovery
CART was found by examining changes in the brain following cocaine or amphetamine administration. CART mRNA increased with cocaine administration2. One of the goals was to find an endogenous anorexigenic substance. CART inhibited rat food intake, as seen when naturally-occurring CART peptides were blocked by injecting antibodies to CART, feeding increased2.
Classification
CART is a neurotransmitter1.
Structural Characteristics
In rat the CART gene encodes a peptide of either 129 or 116 amino acid residues whereas only the short form exists in humans3. The predicted signal sequence is 27 amino acid residues resulting in a propeptide of 102 or 89 residues3. The C-terminal end of CART, consisting of 48 amino acid residues and 3 disulphide bonds, is thought to constitute a biologically active part of the molecule3.
Mode of action
The putative receptor target for CART has not yet been identified, however in vitro studies strongly suggest that CART binds to a specific G protein-coupled receptor resulting in increased ERK release inside the cell4.
Functions
CART, a neurotrasnmittor produces similar behaviour in animals to cocaine and amphetamine, but conversely blocks the effects of cocaine when they are co-administered. The peptide is found in several areas of the brain. When CART is injected into rat brain, increased locomotor activity is seen, which is one of the signs of "central stimulation" caused by substances such as cocaine and amphetamine5. CART peptides, particularly CART (55–102), seem to have an important function in the regulation of energy homeostasis, and interact with several central appetite circuits6. CART is released in response to repeated dopamine release in the nucleus accumbens, and may regulate the activity of neurons in this area. CART production is upregulated by CREB, a protein thought to be involved with the development of drug addiction, and CART may be an important therapeutic target in the treatment of stimulant abuse7.
References
1. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S (1998). Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature, 393 (6680): 72–6.
2. Spiess, J., Villarreal, J., Vale, W (1981). Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus. Biochemistry, 20 (7), 1982–1988.
3. Thim L, Kristensen P, Larsen P.J and Wulff BS (1998). CART, a new anorectic peptide. The International Journal of Biochemistry & Cell Biology, 30 (12), 1281-128.
4. Lakatos A, Prinster S, Vicentic A, Hall RA, Kuhar MJ (2005). Cocaine- and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors. Neuroscience Lett., 384 (1-2): 198–202.
6. Kuhar MJ, Adams S, Dominguez G, Jaworski J, Balkan B (2002). CART peptides. Neuropeptides, 36 (1): 1–8.
7. Murphy KG (2005). Dissecting the role of cocaine- and amphetamine-regulated transcript (CART) in the control of appetite. Brief Funct Genomic Proteomic, 4 (2): 95–111.
8. Fagergren P, Hurd Y (2007). CART mRNA expression in rat monkey and human brain: relevance to cocaine abuse. Physiology & Behavior, 92 (1-2): 218–25.
Cocaine and amphetamine regulated transcript (CART) is a neuropeptide which in humans is encoded by the CARTPT gene and has roles in reward, feeding, and stress, and it has the functional properties of an endogenous psychostimulant1.
Discovery
CART was found by examining changes in the brain following cocaine or amphetamine administration. CART mRNA increased with cocaine administration2. One of the goals was to find an endogenous anorexigenic substance. CART inhibited rat food intake, as seen when naturally-occurring CART peptides were blocked by injecting antibodies to CART, feeding increased2.
Classification
CART is a neurotransmitter1.
Structural Characteristics
In rat the CART gene encodes a peptide of either 129 or 116 amino acid residues whereas only the short form exists in humans3. The predicted signal sequence is 27 amino acid residues resulting in a propeptide of 102 or 89 residues3. The C-terminal end of CART, consisting of 48 amino acid residues and 3 disulphide bonds, is thought to constitute a biologically active part of the molecule3.
Mode of action
The putative receptor target for CART has not yet been identified, however in vitro studies strongly suggest that CART binds to a specific G protein-coupled receptor resulting in increased ERK release inside the cell4.
Functions
CART, a neurotrasnmittor produces similar behaviour in animals to cocaine and amphetamine, but conversely blocks the effects of cocaine when they are co-administered. The peptide is found in several areas of the brain. When CART is injected into rat brain, increased locomotor activity is seen, which is one of the signs of "central stimulation" caused by substances such as cocaine and amphetamine5. CART peptides, particularly CART (55–102), seem to have an important function in the regulation of energy homeostasis, and interact with several central appetite circuits6. CART is released in response to repeated dopamine release in the nucleus accumbens, and may regulate the activity of neurons in this area. CART production is upregulated by CREB, a protein thought to be involved with the development of drug addiction, and CART may be an important therapeutic target in the treatment of stimulant abuse7.
References
1. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S (1998). Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature, 393 (6680): 72–6.
2. Spiess, J., Villarreal, J., Vale, W (1981). Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus. Biochemistry, 20 (7), 1982–1988.
3. Thim L, Kristensen P, Larsen P.J and Wulff BS (1998). CART, a new anorectic peptide. The International Journal of Biochemistry & Cell Biology, 30 (12), 1281-128.
4. Lakatos A, Prinster S, Vicentic A, Hall RA, Kuhar MJ (2005). Cocaine- and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors. Neuroscience Lett., 384 (1-2): 198–202.
6. Kuhar MJ, Adams S, Dominguez G, Jaworski J, Balkan B (2002). CART peptides. Neuropeptides, 36 (1): 1–8.
7. Murphy KG (2005). Dissecting the role of cocaine- and amphetamine-regulated transcript (CART) in the control of appetite. Brief Funct Genomic Proteomic, 4 (2): 95–111.
8. Fagergren P, Hurd Y (2007). CART mRNA expression in rat monkey and human brain: relevance to cocaine abuse. Physiology & Behavior, 92 (1-2): 218–25.
Apelin Peptides
Definition
Apelin, a peptide first isolated from bovine stomach tissue extracts, is the endogenous ligand of the human G protein-coupled orphan APJ receptor. The ligand was named “Apelin” after APJ endogenous ligand.
Discovery
In 1993, O’Dowd et al. identified the gene for G-protein coupled receptor, named APJ, which shows about 30 % homology to the angiotensin receptor (AT-1)1. Thus, APJ remained an “orphaned” receptor until 1998 when Tatemoto et al. discovered the peptide apelin. These authors found that peptide-enriched fractions of bovine stomach-extracts promoted extra-cellular acidification rates of cells expressing the APJ receptor. By monitoring this activity, they purified, sequenced a 36 amino acid peptide named apelin2.
Structural characteristics
Apelin is a 36-aa peptide derived from a 77-aa precursor, preproapelin, for which cDNAs have been cloned from humans and animals. In all species a sequence of 23 amino acids in the C-terminal region is conserved, and is critical for biological activity.77-aa preproapelin contains a number of basic amino acid pairs (Arg – Arg, Arg – Lys) are the proteolytic cleavage site for endopeptidase. The endogenous forms detected (by chromatographic separation and immunoassay) comprise predominantly Apelin – 36, – 17, – 13 and following post translation modification by enzymatic conversion of N - terminal glutamate by pyroglutamate [Pyr1 ]. This modification confers resistance to degradation by peptidase2.
Mechanism of action
The transduction pathways for apelin signal depends on the interaction with a G-protein coupled to the APJ receptor, independently of Ras protein; although dependent on Protein Kinase C (PKC). If PKC, phospholipase C, the Na+-H+ and Na+-Ca2+ exchanger are inhibited, apelin effects significantly reduces (positive inotropic effect).
In addition to adenyl cyclase inhibition pathway, apelin activates ERKs (extracellular regulated kinases) pathways through a PTX (pertussis toxin) sensitive G-protein, in a PKC-dependent process. Endothelial cells proliferation control is also activated by apelin through two mechanisms: one is ERK-dependent and the other is PI3K-dependent. PI3K/Akt seems to be responsible for the phosphorilation and resulting activation of endothelial nitric oxide synthase, which is indispensable for apelin vasoactive effects3.
Functions
Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility- apelin exhibit high levels of mRNA expression in the heart. In isolated perfused rat hearts, infusion of apelin induced a dose-dependent positive inotropic effect. Inhibition of phospholipase C with U-73122 and suppression of protein kinase C with stauzrosporine and markedly attenuated the apelin-induced inotropic effect4.
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism - mean arterial pressure after the administration of apelin-13, and apelin-36 in doses of 10 nmol/kg in anaesthetized rats was reduced by 11+/-4, and 5+/-4 mm Hg, respectively2.
Apelin-immunoreactivity in the rat hypothalamus and pituitary- Apelin-immunoreactive (IR) neurons are particularly abundant in hypothalamic nuclei, i.e., the supraoptic (SON), paraventricular (PVN) nuclei. It suggests that apelin-containing cell bodies of the SON and PVN, like arginine vasopressin (AVP) - and oxytocin (OXY)-containing magnocellular neurons, project toward the neural lobe of the pituitary. These two neurohormones released from posterior-pituitary into systemic circulation, control fluid balance and milk ejection/uterus contractility. Also it has been reported that apelin IR colocalizes with neurophysin-I in a population of SON and PVN magnocellular neurons, indicating that apelin is expressed by OXY neurons5.
The effects of centrally administered apelin-13 on rats - Preproapelin and APJ mRNA are found in hypothalamic regions known to be important in the regulation of food and water intake, and pituitary hormone release. The intracerebroventricular administration of pyroglutamylated apelin-13 on rats had little effect on food intake, but dose-dependently increased drinking behaviour and water intake. Apelin-13 increased water intake and also significantly increased plasma ACTH and corticosterone and decreased plasma prolactin, LH and FSH (endocrine axes), compared to saline control6.
References
1.O’Dowd, Heiber, Chan A, Heng, Tsui, Kennedy JL, Petronis A (1993). A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene.,136:355–360.
2.Tatemoto K, Hosoya, Habata, Fujii R, Kakegawa T, Kawamata Y, Hinuma S, Kitada, Kurokawa T, Onda (1998). Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun., 251:471–476
3.Ricardo Ladeiras-Lopes, João Ferreira-Martins, Adelino F. Leite-Moreira (2008). Apelinergic System: The Role Played in Human Physiology and Pathology and Potential Therapeutic Applications. Arq. Bras. Cardiol., 90(5): 343-349.
4.Szokodi I, Tavi, Foldes G, Voutilainen-Myllyla S, Tokola H (2002). Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res., 91 (5): 434-40.
5.Brailoiu C, Dun SL, Yang J, Ohsawa M, & Dun NJ (2002). Apelin-immunoreactivity in the rat hypothalamus and pituitary. Neurosci. Lett. 327 , 193–197.
6.Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, Dhillo W, Dakin C, Sajedi A, Ghatei M, Bloom S (2002). The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem. Biophys. Res. Commun., 291: 1208–1212.
Apelin, a peptide first isolated from bovine stomach tissue extracts, is the endogenous ligand of the human G protein-coupled orphan APJ receptor. The ligand was named “Apelin” after APJ endogenous ligand.
Discovery
In 1993, O’Dowd et al. identified the gene for G-protein coupled receptor, named APJ, which shows about 30 % homology to the angiotensin receptor (AT-1)1. Thus, APJ remained an “orphaned” receptor until 1998 when Tatemoto et al. discovered the peptide apelin. These authors found that peptide-enriched fractions of bovine stomach-extracts promoted extra-cellular acidification rates of cells expressing the APJ receptor. By monitoring this activity, they purified, sequenced a 36 amino acid peptide named apelin2.
Structural characteristics
Apelin is a 36-aa peptide derived from a 77-aa precursor, preproapelin, for which cDNAs have been cloned from humans and animals. In all species a sequence of 23 amino acids in the C-terminal region is conserved, and is critical for biological activity.77-aa preproapelin contains a number of basic amino acid pairs (Arg – Arg, Arg – Lys) are the proteolytic cleavage site for endopeptidase. The endogenous forms detected (by chromatographic separation and immunoassay) comprise predominantly Apelin – 36, – 17, – 13 and following post translation modification by enzymatic conversion of N - terminal glutamate by pyroglutamate [Pyr1 ]. This modification confers resistance to degradation by peptidase2.
Mechanism of action
The transduction pathways for apelin signal depends on the interaction with a G-protein coupled to the APJ receptor, independently of Ras protein; although dependent on Protein Kinase C (PKC). If PKC, phospholipase C, the Na+-H+ and Na+-Ca2+ exchanger are inhibited, apelin effects significantly reduces (positive inotropic effect).
In addition to adenyl cyclase inhibition pathway, apelin activates ERKs (extracellular regulated kinases) pathways through a PTX (pertussis toxin) sensitive G-protein, in a PKC-dependent process. Endothelial cells proliferation control is also activated by apelin through two mechanisms: one is ERK-dependent and the other is PI3K-dependent. PI3K/Akt seems to be responsible for the phosphorilation and resulting activation of endothelial nitric oxide synthase, which is indispensable for apelin vasoactive effects3.
Functions
Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility- apelin exhibit high levels of mRNA expression in the heart. In isolated perfused rat hearts, infusion of apelin induced a dose-dependent positive inotropic effect. Inhibition of phospholipase C with U-73122 and suppression of protein kinase C with stauzrosporine and markedly attenuated the apelin-induced inotropic effect4.
The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism - mean arterial pressure after the administration of apelin-13, and apelin-36 in doses of 10 nmol/kg in anaesthetized rats was reduced by 11+/-4, and 5+/-4 mm Hg, respectively2.
Apelin-immunoreactivity in the rat hypothalamus and pituitary- Apelin-immunoreactive (IR) neurons are particularly abundant in hypothalamic nuclei, i.e., the supraoptic (SON), paraventricular (PVN) nuclei. It suggests that apelin-containing cell bodies of the SON and PVN, like arginine vasopressin (AVP) - and oxytocin (OXY)-containing magnocellular neurons, project toward the neural lobe of the pituitary. These two neurohormones released from posterior-pituitary into systemic circulation, control fluid balance and milk ejection/uterus contractility. Also it has been reported that apelin IR colocalizes with neurophysin-I in a population of SON and PVN magnocellular neurons, indicating that apelin is expressed by OXY neurons5.
The effects of centrally administered apelin-13 on rats - Preproapelin and APJ mRNA are found in hypothalamic regions known to be important in the regulation of food and water intake, and pituitary hormone release. The intracerebroventricular administration of pyroglutamylated apelin-13 on rats had little effect on food intake, but dose-dependently increased drinking behaviour and water intake. Apelin-13 increased water intake and also significantly increased plasma ACTH and corticosterone and decreased plasma prolactin, LH and FSH (endocrine axes), compared to saline control6.
References
1.O’Dowd, Heiber, Chan A, Heng, Tsui, Kennedy JL, Petronis A (1993). A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene.,136:355–360.
2.Tatemoto K, Hosoya, Habata, Fujii R, Kakegawa T, Kawamata Y, Hinuma S, Kitada, Kurokawa T, Onda (1998). Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem. Biophys. Res. Commun., 251:471–476
3.Ricardo Ladeiras-Lopes, João Ferreira-Martins, Adelino F. Leite-Moreira (2008). Apelinergic System: The Role Played in Human Physiology and Pathology and Potential Therapeutic Applications. Arq. Bras. Cardiol., 90(5): 343-349.
4.Szokodi I, Tavi, Foldes G, Voutilainen-Myllyla S, Tokola H (2002). Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res., 91 (5): 434-40.
5.Brailoiu C, Dun SL, Yang J, Ohsawa M, & Dun NJ (2002). Apelin-immunoreactivity in the rat hypothalamus and pituitary. Neurosci. Lett. 327 , 193–197.
6.Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, Dhillo W, Dakin C, Sajedi A, Ghatei M, Bloom S (2002). The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem. Biophys. Res. Commun., 291: 1208–1212.
Guanylins
Definition
Guanylins are small, heat-stable peptides that bind to and activate Guanylyl cyclase-C (GC-C) receptors to regulate intestinal and renal fluid and electrolyte transport through secondary messenger, cyclic guanosine 39,59-monophosphate (cGMP)1.
Related peptides
The guanylin family of cGMP-regulating peptides has three subclasses of peptides containing either three intramolecular disulfides found in bacterial heat-stable enterotoxins (ST), or two disulfides observed in guanylin and uroguanylin, or a single disulfide exemplified by lymphoguanylin2. The major endogenous guanylin molecule in human intestine and plasma is 10-kDa proguanylin, 15-amino acid guanylin being a minor component. Human guanylin is distributed widely from the duodenum to colon, the highest contents being in the ileum and proximal colon3.
Discovery
Guanylin and uroguanylin are novel peptides that were first isolated from rat jejunum and opossum urine, respectively. Guanylin was purified and sequenced using automated Edman degradation sequence analysis and electrospray mass spectrometry by Currie et al in 19914.
Structural characteristics
The circulating hormonal form of guanylin is around 10.3-kDa5. Human GN consists of 15 amino acids and possesses two disulfide bonds between the cysteins in positions 4 to 12 and 7 to 15. Human UGN consists of 16 amino acids and also has two disulfide bonds at the same positions. These disulfide bonds are essential for the activity of the peptides6.
Mechanism of action
Two receptor GC signaling molecules have been identified that are highly expressed in the intestine (GC-C) and/or the kidney (OK-GC) and are selectively activated by the guanylin peptides. Stimulation of cGMP production in renal target cells by guanylin peptides in vivo or ex vivo elicits a long-lived diuresis, natriuresis, and kaliuresis. Activation of GC-C receptors in target cells of intestinal mucosa markedly stimulates the transepithelial secretion of Cl and HCO 3, causing enhanced secretion of fluid and electrolytes into the intestinal lumen. Bacterial ST peptides act as mimics of guanylin and uroguanylin in the intestine, which provide a cellular mechanism underlying the diarrhea caused by ST-secreting strains of Escherichia coli2.
Function
The Guanylin family of peptides is involved in the pathophysiology of some gastrointestinal, renal and heart diseases. Guanylin and uroguanylin may participate in a novel endocrine axis linking the digestive system and kidney as a physiological mechanism that influences Na+ homeostasis. Guanylin, uroguanylin, and/or lymphoguanylin may also serve within intrarenal signaling pathways controlling cGMP production in renal target cells. It has been proposed that guanylin regulatory peptides participate in a complex multifactorial biological process that evolved to regulate the urinary excretion of NaCl when dietary salt levels exceed the body's physiological requirements. This highly inGuanylinstegrated and redundant mechanism allows the organism to maintain sodium balance by eliminating excess NaCl in the urine2.
References
1.Nakazato M (2001). Guanylin family: new intestinal peptides regulating electrolyte and water homeostasis. J Gastroenterol, 36:219–225.
2.Forte LR, London RM, Freeman RH, Krause WJ(2000). Guanylin peptides: renal actions mediated by cyclic GMP. Am J Physiol Renal Physiol 278 (2):180-191.
3.Nakazato M, Yamaguchi H, Shiomi K, Date Y, Fujimoto S, Kangawa K, Matsuo H, Matsukura S (1994). Identification of 10-kDa proguanylin as a major guanylin molecule in human intestine and plasma and its increase in renal insufficiency. Biochem Biophys Res Commun. 205(3):1966-1975.
4.Kuhn M, Raida M, Adermann K, Schulz-Knappe P, Gerzer R, Heim JM, Forssmann WG (1993). The circulating bioactive form of human guanylin is a high molecular weight peptide.FEBS Lett, 318(2): 205-209.
5.Sindic A, Schlatter E(2006).Cellular Effects of Guanylin and Uroguanylin. J Am Soc Nephrol,17(3):607-616.
6.Currie MG, Fok KF, Kato J, Moore RJ, Hamra FK, Duffin KL, Smith CE(1992). Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc Natl Acad Sci U S A, 3: 947-951.
Guanylins are small, heat-stable peptides that bind to and activate Guanylyl cyclase-C (GC-C) receptors to regulate intestinal and renal fluid and electrolyte transport through secondary messenger, cyclic guanosine 39,59-monophosphate (cGMP)1.
Related peptides
The guanylin family of cGMP-regulating peptides has three subclasses of peptides containing either three intramolecular disulfides found in bacterial heat-stable enterotoxins (ST), or two disulfides observed in guanylin and uroguanylin, or a single disulfide exemplified by lymphoguanylin2. The major endogenous guanylin molecule in human intestine and plasma is 10-kDa proguanylin, 15-amino acid guanylin being a minor component. Human guanylin is distributed widely from the duodenum to colon, the highest contents being in the ileum and proximal colon3.
Discovery
Guanylin and uroguanylin are novel peptides that were first isolated from rat jejunum and opossum urine, respectively. Guanylin was purified and sequenced using automated Edman degradation sequence analysis and electrospray mass spectrometry by Currie et al in 19914.
Structural characteristics
The circulating hormonal form of guanylin is around 10.3-kDa5. Human GN consists of 15 amino acids and possesses two disulfide bonds between the cysteins in positions 4 to 12 and 7 to 15. Human UGN consists of 16 amino acids and also has two disulfide bonds at the same positions. These disulfide bonds are essential for the activity of the peptides6.
Mechanism of action
Two receptor GC signaling molecules have been identified that are highly expressed in the intestine (GC-C) and/or the kidney (OK-GC) and are selectively activated by the guanylin peptides. Stimulation of cGMP production in renal target cells by guanylin peptides in vivo or ex vivo elicits a long-lived diuresis, natriuresis, and kaliuresis. Activation of GC-C receptors in target cells of intestinal mucosa markedly stimulates the transepithelial secretion of Cl and HCO 3, causing enhanced secretion of fluid and electrolytes into the intestinal lumen. Bacterial ST peptides act as mimics of guanylin and uroguanylin in the intestine, which provide a cellular mechanism underlying the diarrhea caused by ST-secreting strains of Escherichia coli2.
Function
The Guanylin family of peptides is involved in the pathophysiology of some gastrointestinal, renal and heart diseases. Guanylin and uroguanylin may participate in a novel endocrine axis linking the digestive system and kidney as a physiological mechanism that influences Na+ homeostasis. Guanylin, uroguanylin, and/or lymphoguanylin may also serve within intrarenal signaling pathways controlling cGMP production in renal target cells. It has been proposed that guanylin regulatory peptides participate in a complex multifactorial biological process that evolved to regulate the urinary excretion of NaCl when dietary salt levels exceed the body's physiological requirements. This highly inGuanylinstegrated and redundant mechanism allows the organism to maintain sodium balance by eliminating excess NaCl in the urine2.
References
1.Nakazato M (2001). Guanylin family: new intestinal peptides regulating electrolyte and water homeostasis. J Gastroenterol, 36:219–225.
2.Forte LR, London RM, Freeman RH, Krause WJ(2000). Guanylin peptides: renal actions mediated by cyclic GMP. Am J Physiol Renal Physiol 278 (2):180-191.
3.Nakazato M, Yamaguchi H, Shiomi K, Date Y, Fujimoto S, Kangawa K, Matsuo H, Matsukura S (1994). Identification of 10-kDa proguanylin as a major guanylin molecule in human intestine and plasma and its increase in renal insufficiency. Biochem Biophys Res Commun. 205(3):1966-1975.
4.Kuhn M, Raida M, Adermann K, Schulz-Knappe P, Gerzer R, Heim JM, Forssmann WG (1993). The circulating bioactive form of human guanylin is a high molecular weight peptide.FEBS Lett, 318(2): 205-209.
5.Sindic A, Schlatter E(2006).Cellular Effects of Guanylin and Uroguanylin. J Am Soc Nephrol,17(3):607-616.
6.Currie MG, Fok KF, Kato J, Moore RJ, Hamra FK, Duffin KL, Smith CE(1992). Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc Natl Acad Sci U S A, 3: 947-951.
Monday, August 17, 2009
GSK-3 (Glycogen Synthase Kinase - 3)
Definition
Glycogen synthase kinase 3 (GSK-3) is a multifunctional serine/threonine kinase found in all eukaryotes. This enzyme is a key regulator of numerous signalling pathways, including cellular responses to Wnt, receptor tyrosine kinases and G-protein-coupled receptors and is involved in a wide range of cellular processes, ranging from glycogen metabolism to cell cycle regulation and proliferation1.
Related peptides
Two isoforms of GSK-3 are reported in mammals: a 51 kDa GSK-3 alpha and a 47 kDa GSK-3beta. These two isoforms exhibit about 98% homology in their kinase domains, but share only about 36% identity in the last 76 C-terminal amino acid residues.
Discovery
Glycogen synthase kinase- 3 was identified and purified to homogeneity, from rabbit skeletal muscle by Embi N et al in 19802.
Structural characteristics
GSK-3 is about 47,000 Daltons. GSK-3 comprises an N-terminal lobe composed of beta sheets and a C- terminal lobe that is mainly alpha helical. (4) Arg-96, Arg-180 and Lys-205 are found to be conserved in all identified GSK-3 homologues, suggesting conservation of the priming phosphate binding site and hence the substrate specificity of GSK-3 in all organisms3.
Mechanism of action
GSK-3 shows a preference for target proteins that are pre-phosphorylated at a “priming” residue located C-terminal to the site of GSK-3 phosphorylation. Priming phosphorylation, although not absolutely required, enhances the efficiency of phosphorylation of most GSK-3 substrates. The T-loop of GSK-3alpha is phosphorylated at Tyr279 and GSK-3beta at Tyr216, which play a role in forcing open the substrate-binding site of the enzyme. Uniquely, the T-loop of GSK-3 does not undergo any Thr phosphorylation. The function of missing pThr in the T-loop of GSK-3 is carried out by the phosphorylated residue of a primed substrate that binds to a positively charged pocket consisting of Arg96, Arg180, and Lys205 (for GSK-3beta). This arrangement optimizes the orientation of the kinase domain and places the substrate at the proper position within the catalytic groove for phosphorylation to take place4.
Function
Identified originally as a regulator of glycogen metabolism, glycogen synthase kinase-3 (GSK3) is now a well-established component of the Wnt signaling pathway, which is essential for setting up the entire body pattern during embryonic development. It may also play important roles in protein synthesis, cell proliferation, cell differentiation, microtubule dynamics and cell motility by phosphorylating initiation factors, components of the cell-division cycle, transcription factors and proteins involved in microtubule function and cell adhesion3.
References
1.Doble BW, Woodgett JR (2003). GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci, 116:175-1186.
2.Embi N, Rylatt DB, Cohen P (1980). Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J.Bioche,107:519-527.
3.Frame S, Cohen P (2001). GSK3 takes centre stage more than 20 years after its discovery. Biochem J, 359:1–16.
Glycogen synthase kinase 3 (GSK-3) is a multifunctional serine/threonine kinase found in all eukaryotes. This enzyme is a key regulator of numerous signalling pathways, including cellular responses to Wnt, receptor tyrosine kinases and G-protein-coupled receptors and is involved in a wide range of cellular processes, ranging from glycogen metabolism to cell cycle regulation and proliferation1.
Related peptides
Two isoforms of GSK-3 are reported in mammals: a 51 kDa GSK-3 alpha and a 47 kDa GSK-3beta. These two isoforms exhibit about 98% homology in their kinase domains, but share only about 36% identity in the last 76 C-terminal amino acid residues.
Discovery
Glycogen synthase kinase- 3 was identified and purified to homogeneity, from rabbit skeletal muscle by Embi N et al in 19802.
Structural characteristics
GSK-3 is about 47,000 Daltons. GSK-3 comprises an N-terminal lobe composed of beta sheets and a C- terminal lobe that is mainly alpha helical. (4) Arg-96, Arg-180 and Lys-205 are found to be conserved in all identified GSK-3 homologues, suggesting conservation of the priming phosphate binding site and hence the substrate specificity of GSK-3 in all organisms3.
Mechanism of action
GSK-3 shows a preference for target proteins that are pre-phosphorylated at a “priming” residue located C-terminal to the site of GSK-3 phosphorylation. Priming phosphorylation, although not absolutely required, enhances the efficiency of phosphorylation of most GSK-3 substrates. The T-loop of GSK-3alpha is phosphorylated at Tyr279 and GSK-3beta at Tyr216, which play a role in forcing open the substrate-binding site of the enzyme. Uniquely, the T-loop of GSK-3 does not undergo any Thr phosphorylation. The function of missing pThr in the T-loop of GSK-3 is carried out by the phosphorylated residue of a primed substrate that binds to a positively charged pocket consisting of Arg96, Arg180, and Lys205 (for GSK-3beta). This arrangement optimizes the orientation of the kinase domain and places the substrate at the proper position within the catalytic groove for phosphorylation to take place4.
Function
Identified originally as a regulator of glycogen metabolism, glycogen synthase kinase-3 (GSK3) is now a well-established component of the Wnt signaling pathway, which is essential for setting up the entire body pattern during embryonic development. It may also play important roles in protein synthesis, cell proliferation, cell differentiation, microtubule dynamics and cell motility by phosphorylating initiation factors, components of the cell-division cycle, transcription factors and proteins involved in microtubule function and cell adhesion3.
References
1.Doble BW, Woodgett JR (2003). GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci, 116:175-1186.
2.Embi N, Rylatt DB, Cohen P (1980). Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur. J.Bioche,107:519-527.
3.Frame S, Cohen P (2001). GSK3 takes centre stage more than 20 years after its discovery. Biochem J, 359:1–16.
Gluten Exorphins
Definition
Gluten exorphins are peptides isolated from pepsin hydrolysates of Wheat gluten. They have morphine-like opioid activity and can act like the body's own narcotics, the endorphins1.
Related peptides
Four gluten exorphins were isolated from the enzymatic digest of wheat gluten and were named gluten exorphins A5, A4, B5 and B42.
Discovery
Zioudrou et al. (1979) identified some opioid peptides in the digests of wheat prolamines with endorphin like activity and termed them “exorphins”. Fukudome and Yoshikawa (1992) have since characterized 15 separate amino acid sequences of gluten-exorphin A-5 in a single molecule of wheat1.2.
Structural characteristics
Gluten exorphins A5 (Gly-Tyr-Tyr-Pro-Thr), A4 (Gly-Tyr-Tyr-Pro), B5 (Tyr-Gly-Gly-Trp-Leu) and B4 (Tyr-Gly-Gly-Trp) were isolated from the enzymatic digests of wheat gluten. The structure-activity relationships of gluten exorphins A are unique. The presence of Gly at their N-termini increases their potency. Gluten exorphin B5, which corresponds to [Trp4,Leu5]- enkephalin, shows the most potent activity among these peptides3.
Mechanism of action
In order for exorphins to function as opioid peptides in the central nervous system in vivo they must (a) be produced in the gastrointestinal tract, (b) survive degradation by intestinal proteases, (c) be absorbed, without degradation, into the bloodstream, (d) cross the blood-brain barrier and thereby reach central opiate receptors, and (e) interact as opiates with these receptors2.
Function
Gluten exorphins, which are exogenous opioids, bind to the same cellular receptors that endogenous opioids bind to, thus impacting on the immune system, nerve function, myelination processes, vascular walls, neuromuscular function, and a variety of CNS functions. Such opioids can have an anaesthetizing, analgesic, and addictive effect1.
References
1.Book: The book of Gluten by Stephen J Gislason, Gislason, Stephen J.
2.Fukudome S, Yoshikawa M (1993). Opioid peptides derived from wheat gluten: their isolation and characterization. FEBS Letters, 316:17-19.
3.Zioudrou C, Streaty RA, Klee WA (1979). Opioid peptides derived from food proteins. The exorphins. J. Biol. Chem. 254:2446-2449.
Gluten exorphins are peptides isolated from pepsin hydrolysates of Wheat gluten. They have morphine-like opioid activity and can act like the body's own narcotics, the endorphins1.
Related peptides
Four gluten exorphins were isolated from the enzymatic digest of wheat gluten and were named gluten exorphins A5, A4, B5 and B42.
Discovery
Zioudrou et al. (1979) identified some opioid peptides in the digests of wheat prolamines with endorphin like activity and termed them “exorphins”. Fukudome and Yoshikawa (1992) have since characterized 15 separate amino acid sequences of gluten-exorphin A-5 in a single molecule of wheat1.2.
Structural characteristics
Gluten exorphins A5 (Gly-Tyr-Tyr-Pro-Thr), A4 (Gly-Tyr-Tyr-Pro), B5 (Tyr-Gly-Gly-Trp-Leu) and B4 (Tyr-Gly-Gly-Trp) were isolated from the enzymatic digests of wheat gluten. The structure-activity relationships of gluten exorphins A are unique. The presence of Gly at their N-termini increases their potency. Gluten exorphin B5, which corresponds to [Trp4,Leu5]- enkephalin, shows the most potent activity among these peptides3.
Mechanism of action
In order for exorphins to function as opioid peptides in the central nervous system in vivo they must (a) be produced in the gastrointestinal tract, (b) survive degradation by intestinal proteases, (c) be absorbed, without degradation, into the bloodstream, (d) cross the blood-brain barrier and thereby reach central opiate receptors, and (e) interact as opiates with these receptors2.
Function
Gluten exorphins, which are exogenous opioids, bind to the same cellular receptors that endogenous opioids bind to, thus impacting on the immune system, nerve function, myelination processes, vascular walls, neuromuscular function, and a variety of CNS functions. Such opioids can have an anaesthetizing, analgesic, and addictive effect1.
References
1.Book: The book of Gluten by Stephen J Gislason, Gislason, Stephen J.
2.Fukudome S, Yoshikawa M (1993). Opioid peptides derived from wheat gluten: their isolation and characterization. FEBS Letters, 316:17-19.
3.Zioudrou C, Streaty RA, Klee WA (1979). Opioid peptides derived from food proteins. The exorphins. J. Biol. Chem. 254:2446-2449.
Ghrelins and Associated Peptides
Definition
Ghrelin is an endogenous ligand for the growth hormone secretagogue receptor (GHSR), which is synthesized principally in the stomach and is released in response to acute and chronic changes in nutritional state 1.
Related peptides
The ghrelin gene encodes a precursor protein, preproghrelin. Alternative mRNA splicing and/or proteolytic processing derives ghrelin and other potentially active peptides. The peptide obestatin is derived from the C-terminal region of preproghrelin and has direct effects on cell proliferation2. The ligand des-Gln14-ghrelin, a 27-amino acid peptide with an n-octanoyl modification at Ser3, is identical to ghrelin except for the deletion of one glutamine, and is produced through alternative splicing of the rat ghrelin gene. Des-Gln14-ghrelin has the same potency as ghrelin. On the other hand, the unmodified, des-n-octanoyl form of ghrelin (desacyl ghrelin) has no effect on the elevation of intracellular Ca2+ and GH secretion1. Other peptide hormones (i.e., motilin, TRH, PACAP, GnRH, leptin, FMRF amide, galanin, NPY, NPW) from gut, brain and other tissues also play a role in modulating GH secretion in livestock and lower vertebrate species 3.
Discovery
The discovery of ghrelin was reported by Masayasu Kojima and colleagues in 1999 4.
Structural characteristics
Ghrelin is synthesized as a preprohormone (13kDa), and then proteolytically processed to yield a 28 amino acid peptide (3kDa) with an n-octanoyl modification at its third serine residue, which is essential for its biological activity5.
Mechanism of action
The ghrelin receptor was known well before ghrelin was discovered. Cells within the anterior pituitary bear a growth hormone secretagoue receptor (GHS-R). Ghrelin bind to the GHS-R and stimulates the release of the growth hormone (GH).
Functions
Ghrelin potently induces GH release both in rats and humans. Ghrelin is primarily produced in distinct endocrine cells in the stomach. Ghrelin-producing neurons are also present in the hypothalamic arcuate nucleus, a region that regulates GH release and food intake. Ghrelin is also involved in the stimulation of feeding and the regulation of energy metabolism5.
References
1.Hosoda H, Kojima M, Kangawa K (2002). Ghrelin and the Regulation of Food Intake and Energy Balance. Molecular Interventions, 2(8):494-503.
2.Seim I, Amorim L, Walpole C, Carter S, Chopin LK, Herington AC (2009). Ghrelin gene-related peptides: multi-functional endocrine/autocrine modulators in health and disease. Clin Exp Pharmacol Physiol .
3.Anderson LL, Jeftinija S, Scanes CG, Stromer MH, Lee JS, Jeftinija K, Glavaski-Joksimovic A. (2005). Physiology of ghrelin and related peptides. Domestic Animal Endocrinology, 29(1):111-144.
4.Book: Ghrelin. Chapter 2: Discovery of Ghrelin, an Endogenous Ligand for the Growth-Hormone Secret Agogue Receptor. By Masayasu Kojima, Hiroshi Hosoda, Hiroyuki Kaiya and Kenji Kangawa.
5.Kangawa K, Kojima M, Hosoda H (2004). Ghrelin: discovery and physiological significance. Nippon Rinsho. 62 (9):317-323.
Ghrelin is an endogenous ligand for the growth hormone secretagogue receptor (GHSR), which is synthesized principally in the stomach and is released in response to acute and chronic changes in nutritional state 1.
Related peptides
The ghrelin gene encodes a precursor protein, preproghrelin. Alternative mRNA splicing and/or proteolytic processing derives ghrelin and other potentially active peptides. The peptide obestatin is derived from the C-terminal region of preproghrelin and has direct effects on cell proliferation2. The ligand des-Gln14-ghrelin, a 27-amino acid peptide with an n-octanoyl modification at Ser3, is identical to ghrelin except for the deletion of one glutamine, and is produced through alternative splicing of the rat ghrelin gene. Des-Gln14-ghrelin has the same potency as ghrelin. On the other hand, the unmodified, des-n-octanoyl form of ghrelin (desacyl ghrelin) has no effect on the elevation of intracellular Ca2+ and GH secretion1. Other peptide hormones (i.e., motilin, TRH, PACAP, GnRH, leptin, FMRF amide, galanin, NPY, NPW) from gut, brain and other tissues also play a role in modulating GH secretion in livestock and lower vertebrate species 3.
Discovery
The discovery of ghrelin was reported by Masayasu Kojima and colleagues in 1999 4.
Structural characteristics
Ghrelin is synthesized as a preprohormone (13kDa), and then proteolytically processed to yield a 28 amino acid peptide (3kDa) with an n-octanoyl modification at its third serine residue, which is essential for its biological activity5.
Mechanism of action
The ghrelin receptor was known well before ghrelin was discovered. Cells within the anterior pituitary bear a growth hormone secretagoue receptor (GHS-R). Ghrelin bind to the GHS-R and stimulates the release of the growth hormone (GH).
Functions
Ghrelin potently induces GH release both in rats and humans. Ghrelin is primarily produced in distinct endocrine cells in the stomach. Ghrelin-producing neurons are also present in the hypothalamic arcuate nucleus, a region that regulates GH release and food intake. Ghrelin is also involved in the stimulation of feeding and the regulation of energy metabolism5.
References
1.Hosoda H, Kojima M, Kangawa K (2002). Ghrelin and the Regulation of Food Intake and Energy Balance. Molecular Interventions, 2(8):494-503.
2.Seim I, Amorim L, Walpole C, Carter S, Chopin LK, Herington AC (2009). Ghrelin gene-related peptides: multi-functional endocrine/autocrine modulators in health and disease. Clin Exp Pharmacol Physiol .
3.Anderson LL, Jeftinija S, Scanes CG, Stromer MH, Lee JS, Jeftinija K, Glavaski-Joksimovic A. (2005). Physiology of ghrelin and related peptides. Domestic Animal Endocrinology, 29(1):111-144.
4.Book: Ghrelin. Chapter 2: Discovery of Ghrelin, an Endogenous Ligand for the Growth-Hormone Secret Agogue Receptor. By Masayasu Kojima, Hiroshi Hosoda, Hiroyuki Kaiya and Kenji Kangawa.
5.Kangawa K, Kojima M, Hosoda H (2004). Ghrelin: discovery and physiological significance. Nippon Rinsho. 62 (9):317-323.
Subscribe to:
Posts (Atom)